Article · 17 May 2024
EditorialPublished Jan 2021
Arising Medicines for Coronavirus
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
An oral antiretroviral protease inhibitor currently approved for the treatment of HIV Infection. Lopinavir/ritonavir has been used in clinical trials for the treatment of COVID-19. Results from one small case series found that evidence of clinical benefit with lopinavir/ ritonavir was equivocal. A randomized controlled trial of 200 patients with severe disease found that treatment with lopinavir/ritonavir plus standard care (i.e., oxygen, noninvasive and invasive ventilation, antibiotics, vasopressors, renal replacement therapy, and extracorporeal membrane oxygenation, as necessary) was not associated with an decreased time to clinical improvement compared with standard care alone, and 28-day mortality was similar in both groups. Preliminary results from the UK RECOVERY trial found that there is no beneficial eوٴect of lopinavir/ritonavir in hospitalized patients with COVID-19. Нere was no significant diوٴerence in 28-day mortality, risk of progression to mechanical ventilation, or duration of hospital stay between the two treatment arms (lopinavir/ritonavir versus usual care alone), and the results were consistent in diوٴerent subgroups of patients. Lopinavir/ritonavir may increase the risk of bradycardia, especially in older, critically ill patients. Lopinavir/ ritonavir should only be used in the context of a clinical trial.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 22 Feb 2021
Role on Traditional Medicines Plant Prevention for Novel Coronavirus Pneumonia Covid-19 Pandemic Narrative Review
Review article · 29 Jul 2020
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-COV-2) Inhibition and Other Antiviral Effects of Ethiopian Medicinal Plants and Their Compounds
Review article · 29 Jun 2023
Research Progress of Chinese Medicine against Neo-Coronavirus
Mini review · 27 Jul 2022
Current Medicines for Coronavirus are Chiefly Given Orally or Intravenously
More from this journal
The newest in Journal of Pharmaceutical Sciences & Emerging Drugs.
Research article · 18 Feb 2025
Comparative Biowaiver Study of Moxifloxacin in Immediate Release of Oral Solid Dosage Form
Perspective · 23 Aug 2024
Drug Intoxication in Adolescents: Warning Signs and Prevention
Short communication · 20 Aug 2024
Bio-organic Chemistry Approaches to Modulating Protein- Ligand Interactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Sciences & Emerging Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Maria A Arruda”

